calendar
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 4,494 phase readout · 2,317 8k filing · 2,000 device pma
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 4,494 phase readout · 2,317 8k filing · 2,000 device pma
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: CURIUM. Form: INJECTABLE. Route: INJECTION
Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION
Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL
Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL
Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: CHARTWELL. Form: SOLUTION. Route: ORAL
Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION
Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION
Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION
Sponsor: MYLAN. Form: TABLET. Route: ORAL
Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: RHODES PHARMS. Form: TABLET. Route: ORAL
Sponsor: AVION PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION
Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL
Sponsor: ABBVIE ENDOCRINE INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: PFIZER. Form: INSERT, EXTENDED RELEASE. Route: VAGINAL
Sponsor: PAI HOLDINGS. Form: SOLUTION. Route: ORAL
Sponsor: RISING. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: ORGANON LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ACTAVIS MID ATLANTIC. Form: SYRUP. Route: ORAL